Increased NfL levels were also documented among symptomatic mutation carriers (FTD cases) in relation to presymptomatic mutation carriers (GRN, MAPT, C9orf72) and asymptomatic first-degree non-carrier relatives [36,51,52,53,54,55]. The gene discussed is MAPT; the disease is frontotemporal dementia.